Assembly Biosciences (ASMB) EBITDA Margin (2017 - 2026)
Assembly Biosciences (ASMB) recorded quarterly EBITDA Margin of 114.53% in Q1 2026, down 319.69% quarter-over-quarter from 52.13% in Q4 2025, and down 2046.0% on a YoY basis from 5.89% in Q1 2025.
Assembly Biosciences (ASMB) EBITDA Margin (2017 - 2026) Analysis & Trends
Assembly Biosciences' EBITDA Margin history runs 9 years deep, the most recent figure standing at 114.53% for Q1 2026.
- In Q1 2026, EBITDA Margin fell 2046.0% year-over-year to 114.53%; the TTM figure through Mar 2026 stood at 9.14% (up 11505.0% YoY), while the FY2025 annual figure was 8.23%, up 13310.0% from the prior year.
- EBITDA Margin was 114.53% for Q1 2026 at Assembly Biosciences, down from 52.13% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 52.13% in Q4 2025 to a low of 159.64% in Q1 2024.
- Historically, EBITDA Margin has averaged 106.71% across 4 years, with a median of 122.93% in 2024.
- The sharpest annual moves came in 2025 and 2026: EBITDA Margin soared 19336 bps in 2025, then slumped 2046 bps in 2026.
- A 4-year view of EBITDA Margin shows it stood at 150.33% in 2023, then gained by 6 bps to 141.23% in 2024, then jumped by 137 bps to 52.13% in 2025, then sank by 320 bps to 114.53% in 2026.
- The last three EBITDA Margin figures came in at 114.53% (Q1 2026), 52.13% (Q4 2025), and 83.48% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Assembly Biosciences | 418.96 Mn | 192.36 Mn | - | -114.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -114.53% |
| Dec 31, 2025 | 52.13% |
| Sep 30, 2025 | -83.48% |
| Jun 30, 2025 | -106.21% |
| Mar 31, 2025 | -94.07% |
| Dec 31, 2024 | -141.23% |
| Sep 30, 2024 | -138.44% |
| Jun 30, 2024 | -131.33% |
| Mar 31, 2024 | -159.64% |
| Dec 31, 2023 | -150.33% |
| Sep 30, 2021 | -300.90% |
| Dec 31, 2020 | -3,811.96% |
| Sep 30, 2020 | -10.43% |
| Jun 30, 2020 | 18.95% |
| Mar 31, 2020 | -650.33% |
| Dec 31, 2019 | -568.07% |
| Sep 30, 2019 | -591.18% |
| Jun 30, 2019 | -599.06% |
| Mar 31, 2019 | -693.54% |
| Dec 31, 2018 | -700.21% |